Correlation Between VIRI Old and Regen BioPharma

Can any of the company-specific risk be diversified away by investing in both VIRI Old and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VIRI Old and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between VIRI Old and Regen BioPharma, you can compare the effects of market volatilities on VIRI Old and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VIRI Old with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of VIRI Old and Regen BioPharma.

Diversification Opportunities for VIRI Old and Regen BioPharma

-0.06

Correlation Coefficient

VIRI Old  Regen BioPharma

Good diversification

The 3 months correlation between VIRI and Regen is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding VIRI Old and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and VIRI Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VIRI Old are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of VIRI Old i.e., VIRI Old and Regen BioPharma go up and down completely randomly.

Pair Corralation between VIRI Old and Regen BioPharma

Given the investment horizon of 90 days VIRI Old is expected to under-perform the Regen BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, VIRI Old is 2.18 times less risky than Regen BioPharma. The stock trades about -0.08 of its potential returns per unit of risk. The Regen BioPharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  15.00  in Regen BioPharma on October 24, 2024 and sell it today you would lose (7.03) from holding Regen BioPharma or give up 46.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	54.84%
Values	Daily Returns

VIRI Old  vs.  Regen BioPharma

VIRI Old

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VIRI Old has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Regen BioPharma

Risk-Adjusted Performance

5 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with VIRI Old and Regen BioPharma

The main advantage of trading using opposite VIRI Old and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VIRI Old position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.

The idea behind VIRI Old and Regen BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.